Abstract
When a patient is found to have multiple lung tumors, distinguishing whether they represent metastatic nodules or separate primary cancers is crucial for staging and therapy. We report the case of a 79-year-old patient with two surgically resected synchronous left upper lobe adenocarcinomas initially pathologically staged as T3 (IIB), indicating adjuvant chemotherapy should be recommended. However, the tumors appeared radiographically distinct, so next-generation sequencing was performed on each nodule. Each tumor harbored a different mesenchymal-to-epithelial transition (MET) exon 14 skipping mutation, an emerging targetable mutation, suggestive of distinct clonality. While the in frame protein deletion was the same in each tumor, the nucleotide base substitutions were different. Thus, the patient was down-staged to having two separate IA tumors, spared of adjuvant chemotherapy, and routine surveillance was recommended. This case highlights the utility of using molecular analysis in diagnosing and treating multifocal lung tumors, and the process of convergent molecular evolution toward a common oncogenic driver mutation. This is the first case of multiple synchronous lung tumors each harboring a distinct MET exon 14 splice sit...Continue Reading
References
Dec 20, 2003·Nature Reviews. Molecular Cell Biology·Carmen BirchmeierGeorge F Vande Woude
May 1, 2007·The Journal of Thoracic and Cardiovascular Surgery·Delphine TroussePascal Thomas
Aug 29, 2007·The Journal of Thoracic and Cardiovascular Surgery·Yih-Leong ChangYung-Chie Lee
Apr 21, 2009·Chest·Nicolas GirardWilliam Pao
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicolas GirardColin B Begg
Oct 22, 2009·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jin-Haeng ChungChoon-Taek Lee
Dec 22, 2009·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Luca VoltoliniGiuseppe Gotti
Jan 27, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·David J FinleyBernard J Park
Dec 15, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eun Jung JungSang-Won Um
Jun 29, 2013·The Annals of Thoracic Surgery·Bo GuJoseph B Shrager
Sep 12, 2013·The Annals of Thoracic Surgery·Yu-Chao YuWen-Hu Hsu
Aug 1, 2014·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jan 27, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Long JiangJianxing He
Apr 16, 2015·American Journal of Clinical Pathology·Robert J Homer
May 15, 2015·Cancer Discovery·Garrett M FramptonVincent A Miller
May 15, 2015·Cancer Discovery·Paul K PaikMarc Ladanyi
Jul 29, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xuewen LiuAlain C Borczuk
Apr 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisUNKNOWN International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and Advisory Board Members
Oct 27, 2016·Chest·Frank C DetterbeckLynn T Tanoue
Feb 12, 2017·Cell·Nicholas McGranahan, Charles Swanton
Feb 28, 2017·Radiology·Heber MacMahonAlexander A Bankier
Apr 27, 2017·The New England Journal of Medicine·Mariam Jamal-HanjaniUNKNOWN TRACERx Consortium
Jul 27, 2017·Clinical Lung Cancer·Mark F BerryJoseph Shrager
Citations
Dec 22, 2019·Cancers·Subba R DigumarthyRebecca S Heist
Aug 22, 2020·World Journal of Clinical Oncology·Dexter P MendozaSubba R Digumarthy
Feb 3, 2020·The Journal of Thoracic and Cardiovascular Surgery·Richard ZhengNathaniel R Evans